Cochrane Review Group
HIV/AIDS
36 systematic reviews in HIV/AIDS ask 473 questions. 8% have no studies to answer them, 26.6% rest on very low certainty evidence and 36.5% reach moderate or high certainty.
Reviews
36
Questions
473
current versions
No studies
8%
Moderate or high
36.5%
No studies 38 · 8%Ungraded 9 · 1.9%Very low 126 · 26.6%Low 127 · 26.8%Moderate 152 · 32.1%High 21 · 4.4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Bleomycin vs ABV Mortality · HIV‐infected adults with severe (T1) Kaposi's sarcoma Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults (2014) · Cochrane | RR 1.09 [0.87, 1.36] | 1 study · 24 participants | Very low |
Bleomycin vs ABV Clinical response ‐ complete response · HIV‐infected adults with severe (T1) Kaposi's sarcoma Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults (2014) · Cochrane | no estimate extracted | 1 study · 24 participants | Very low |
Bleomycin vs ABV Clinical response ‐ partial response · HIV‐infected adults with severe (T1) Kaposi's sarcoma Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults (2014) · Cochrane | RR 0.11 [0.01, 1.86] | 1 study · 24 participants | Very low |
Bleomycin vs ABV Clinical response ‐ stable disease · HIV‐infected adults with severe (T1) Kaposi's sarcoma Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults (2014) · Cochrane | RR 0.88 [0.47, 1.63] | 1 study · 24 participants | Very low |
Bleomycin vs ABV Clinical response ‐ progression · HIV‐infected adults with severe (T1) Kaposi's sarcoma Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults (2014) · Cochrane | RR 11 [0.67, 179.29] | 1 study · 24 participants | Very low |
Bleomycin vs ABV Adverse events · HIV‐infected adults with severe (T1) Kaposi's sarcoma Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults (2014) · Cochrane | RR 11 [0.67, 179.29] | 1 study · 24 participants | Very low |
Doctor vs nurse or clinical officer Lost to · HIV infected patients on antiretroviral therapy Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy (2014) · Cochrane | RR 0.34 [0.18, 0.66] | 1 study · 2772 participants | Very low |
Doctor vs nurse or clinical officer Death or loss to · HIV infected patients on antiretroviral therapy Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy (2014) · Cochrane | RR 0.3 [0.17, 0.54] | 1 study · 2772 participants | Very low |
Doctor vs community health worker Outcomes2 · HIV infected patients on antiretroviral therapy. Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy (2014) · Cochrane | no estimate extracted | NR | No studies |
Doctor vs nurse or clinical officer Lost to · HIV‐infected patients Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy (2014) · Cochrane | RR 0.3 [0.05, 1.94] | 2 studies · 39156 participants | Very low |
Doctor vs nurse or clinical officer Death or loss to · HIV‐infected patients Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy (2014) · Cochrane | RR 0.72 [0.48, 1.07] | 2 studies · 39160 participants | Very low |
Doctor vs nurse or clinical officer Death (Cohorts) · HIV infected patients on antiretroviral therapy Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy (2014) · Cochrane | RR 0.19 [0.05, 0.78] | 1 study · 2772 participants | Very low |
Reviews 36
Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupational settings
CochraneSoF table
2 questions
Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high‐income countries
CochraneSoF table
4 questions
Male circumcision for prevention of homosexual acquisition of HIV in men
CochraneSoF table
6 questions
Behavioral interventions to promote condom use among women living with HIV
CochraneSoF table
4 questions
Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection
CochraneSoF table
14 questions
Antiretroviral regimens for patients with HIV who fail first‐line antiretroviral therapy
CochraneSoF table
6 questions
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults
CochraneSoF table
3 questions
Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women
CochraneSoF table
47 questions
Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection
CochraneSoF table
28 questions
Stavudine or zidovudine in three‐drug combination therapy for initial treatment of HIV infection in antiretroviral‐naïve individuals
CochraneSoF table
7 questions
Tenofovir or zidovudine in three‐drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non‐nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral‐naïve individuals
CochraneSoF table
5 questions